The LCA5 gene therapy will be the first emerging Opus treatment to move into a human study

SparingVision Receives Authorization to Launch US Clinical Trial for its Cone-Preserving Treatment

The Foundation Fighting Blindness is the driving force in the global development of treatments and cures for blinding diseases. To learn more, go to FightingBlindness.org.